HA-cdh1 Citations (11)
Originally described in: Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex.Pfleger CM, Lee E, Kirschner MW Genes Dev. 2001 Sep 15. 15(18):2396-407. PubMed Journal
Articles Citing HA-cdh1
| Articles |
|---|
| Hypoxia and cell cycle regulation of the von Hippel-Lindau tumor suppressor. Liu W, Xin H, Eckert DT, Brown JA, Gnarra JR. Oncogene. 2011 Jan 6;30(1):21-31. doi: 10.1038/onc.2010.395. Epub 2010 Aug 30. PubMed |
| The histone acetyltransferase component TRRAP is targeted for destruction during the cell cycle. Ichim G, Mola M, Finkbeiner MG, Cros MP, Herceg Z, Hernandez-Vargas H. Oncogene. 2014 Jan 9;33(2):181-92. doi: 10.1038/onc.2012.570. Epub 2013 Jan 14. PubMed |
| WEE1 murine deficiency induces hyper-activation of APC/C and results in genomic instability and carcinogenesis. Vassilopoulos A, Tominaga Y, Kim HS, Lahusen T, Li B, Yu H, Gius D, Deng CX. Oncogene. 2014 Aug 4;0. doi: 10.1038/onc.2014.239. PubMed |
| APC/C(Cdh1) controls CtIP stability during the cell cycle and in response to DNA damage. Lafranchi L, de Boer HR, de Vries EG, Ong SE, Sartori AA, van Vugt MA. EMBO J. 2014 Dec 1;33(23):2860-79. doi: 10.15252/embj.201489017. Epub 2014 Oct 27. PubMed |
| Kinase-controlled phase transition of membraneless organelles in mitosis. Rai AK, Chen JX, Selbach M, Pelkmans L. Nature. 2018 Jul;559(7713):211-216. doi: 10.1038/s41586-018-0279-8. Epub 2018 Jul 4. PubMed |
| E2F1 binds to the peptide-binding groove within the BIR3 domain of cIAP1 and requires cIAP1 for chromatin binding. Allegre J, Cartier J, Glorian V, Droin N, Dumetier B, Kayaci C, Berthelet J, Gemble S, Vuillier C, Maillet L, Garrido C, Dubrez L. PLoS One. 2018 Oct 25;13(10):e0206253. doi: 10.1371/journal.pone.0206253. eCollection 2018. PubMed |
| Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells. Manzione MG, Rombouts J, Steklov M, Pasquali L, Sablina A, Gelens L, Qian J, Bollen M. Mol Biol Cell. 2020 Mar 15;31(6):419-438. doi: 10.1091/mbc.E19-12-0698. Epub 2020 Jan 22. PubMed |
| FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation. Jeong K, Murphy JM, Ahn EE, Lim SS. Cardiovasc Res. 2022 Mar 16;118(4):1150-1163. doi: 10.1093/cvr/cvab132. PubMed |
| Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy. Kildey K, Gandhi NS, Sahin KB, Shah ET, Boittier E, Duijf PHG, Molloy C, Burgess JT, Beard S, Bolderson E, Suraweera A, Richard DJ, O'Byrne KJ, Adams MN. Commun Biol. 2021 May 28;4(1):638. doi: 10.1038/s42003-021-02136-8. PubMed |
| APC/C CDH1 ubiquitinates IDH2 contributing to ROS increase in mitosis. Lambhate S, Bhattacharjee D, Jain N. Cell Signal. 2021 Oct;86:110087. doi: 10.1016/j.cellsig.2021.110087. Epub 2021 Jul 13. PubMed |
| HN1 Is Enriched in the S-Phase, Phosphorylated in Mitosis, and Contributes to Cyclin B1 Degradation in Prostate Cancer Cells. Javed A, Ozduman G, Varisli L, Ozturk BE, Korkmaz KS. Biology (Basel). 2023 Jan 26;12(2):189. doi: 10.3390/biology12020189. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.